Bipolar Disorder Clinical Trials

Showing 61-80 of 605 trials

Magnetic Seizure Therapy in Bipolar Depression (MST-BpD) and Treatment Resistant Depression (MST-TRD)

NCT04080778

The purpose of this study is to compare the efficacy and side effects magnetic seizure therapy (MST) and electroconvulsive therapy (ECT) in Bipolar Depression (MST-BpD) and Treatment Resistant Depression (MST-TRD).

Bipolar Disorder

Joao L. DeQuevedo60 participantsStarted Aug 2024

Houston, Texas, United States

RECRUITINGPhase 1/2

Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine

NCT07185815

The purpose of this study is to assess the PK, Safety, Tolerability (all cohorts) and Efficacy (cohort 3), of once-a-month long-acting SC injection of dose escalating Cariprazine Depot in subjects eligible for treatment with oral Cariprazine.

Major Depressive Disorder (MDD)Bipolar 1 DisorderSchizophrenia

Mapi Pharma Ltd.24 participantsStarted Aug 2025

Ness Ziona, Israel • Ramat Gan, Israel • Tel Aviv, Israel

Magnetic Seizure Therapy in Bipolar Depression (MST-BpD) and Treatment Resistant Depression (MST-TRD)

Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine

Related Searches

HD-tDCS for Adolescent Bipolar Depression Targeting S1

Three-level Model of DBT-informed Care for Youth With and/or at Familial Risk for Bipolar Disorder (DB3)

Mobile Self-Tracking of Mental Health

Pragmatic Patient-oriented Extension Study of Dialectical Behavior Therapy Booster Sessions for Youth With and/or at Familial Risk for Bipolar Disorder

Dialectical Behavior Therapy for Youth With and/or at Familial Risk for Bipolar Disorder

Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression

Post-Hospital Intervention for Veterans With Comorbid Bipolar and Substance Use Disorders

Brain Circuitry Analysis in Bipolar Disorder

Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Disorder

BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study

A Trial of the Fatty Acid Amide Hydrolase Inhibitor Palmitoylethanolamide in Bipolar Depression

Behavioural Activation Therapy and Esketamine for Resistant Depression

Feasibility and Preliminary Results of the Efficacy of Blue-Blocking Glasses on Manic Symptoms in Bipolar Disorder

Reducing Suicide Risk in Adolescents and Young Adults Via a Psychobehavioral Intervention to Regularize Daily Rhythms

Assessment and Treatment for Chronic Pain in Veterans With Serious Mental Illness

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)

The Police-Mental Health Linkage System

NeuroPsyBiT-BD Omics: Genomic & Epigenomic Biobank of Bipolar Disorder